Finance

Lists
OCGN:NASDAQ
Ocugen Inc
$1.30
-1.52%
(-0.020) 1D
Aug 31, 3:29:35 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCGN...
Open
$1.32
High
$1.34
Low
$1.28
Mkt. cap
440.84M
Avg. vol.
4.14M
Volume
2.87M
52-wk high
$2.72
52-wk low
$1.00
EPS
-$0.25
Beta
2.21
Shares outstanding
339.11M
No. of employees
116
Open
$1.32
High
$1.34
Low
$1.28
Mkt. cap
440.84M
Avg. vol.
4.14M
Volume
2.87M
52-wk high
$2.72
52-wk low
$1.00
EPS
-$0.25
Beta
2.21
Shares outstanding
339.11M
No. of employees
116
About Ocugen Inc
CEOShankar Musunuri
Employees116
Founded2013
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteocugen.com
Analyst ratings
Based on 4 analysts giving stock ratings to OCGN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OCGN in the last 3 months.
Highest
Current $1.30
$12.00 (+823.08%)
Average
$10.25 (+688.46%)
Lowest
$8.00 (+515.38%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Reiterated
$8.00
+515.4%
08/10/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$11.00
+746.2%
08/06/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$12.00
+823.1%
08/07/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$10.00
+669.2%
08/07/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$7.00
+438.5%
05/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$10.00
+669.2%
05/06/2026
Elemer Piros
Lucid Capital
Buy
Maintained
$22.00
+1,592.3%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.75M
-193.00K
1.53M
1.49M
Cost of goods sold
11.15M
10.67M
11.26M
10.69M
Cost of revenue
11.15M
10.67M
11.26M
10.69M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.23M
6.13M
8.12M
7.24M
Operating expense
8.23M
6.13M
8.12M
7.24M
Total operating expenses
19.38M
16.80M
19.37M
17.93M
Operating income
-17.62M
-17.00M
-17.84M
-16.44M
Other non operating income
-1.32M
477.00K
-150.00K
-1.97M
EBT including unusual items
-20.05M
-17.71M
-19.18M
-24.88M
EBT excluding unusual items
-20.05M
-17.71M
-19.18M
-22.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.05M
-17.71M
-19.18M
-24.88M
Net profit margin
-1,144.46%
9,174.09%
-1,250.95%
-1,671.84%
Earnings per share
-0.07
-0.06
-0.06
-0.06
Interest and investment income
207.00K
144.00K
132.00K
395.00K
Interest expense
-1.31M
-1.33M
-1.32M
-4.48M
Net interest expenses
-1.11M
-1.19M
-1.19M
-4.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.68M
-16.40M
-17.25M
-15.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps